A Cancer Research Continuum - The Martin D. Abeloff Scholars Program
Date: April 1, 2007
The goals of cancer prevention and control are understanding the causesand risk factors for cancer in healthy populations; the discovery and development of new approaches to cancer chemoprevention; and the implementation and assessment of community-based initiatives, including cancer risk reduction and cancer screening.
The next generation of specialists in cancer prevention and control must betrained in multidisciplinary science and have the skills to translate basic science to community-based interventions and clinical outcomes. These specialists will have to address the ever-increasing burden of cancer worldwide and the special needs of millions of cancer survivors. The Johns Hopkins Kimmel Cancer Center is a unique and ideal training venue for these specialists. To prepare these specialists, the Martin D. Abeloff, M.D. Scholars Program in Cancer Prevention and Control is being established and will include the Martin D. Abeloff, M.D. Faculty Scholar and Martin D. Abeloff, M.D., Scholars-in-Training.
The Faculty Scholar will be one of the world’s most outstanding scholars of cancer prevention and control with a focus on minority candidates. Scholars will spend three years in basic laboratory or population- based investigations and in formal training in translational research skills.
The Scholars-in-Training will be senior postdoctoral fellows, oncology fellows, or scientists who are looking to develop an academic career in translational research in cancer prevention and control. The Abeloff Scholars Program will support salary and benefits for a two-year period. The Scholars-in-Training will have a strong foundation in one of the basic sciences, clinical sciences, or population sciences and will identify a laboratory focus and a collaborative research activity to broaden their opportunities in clinical and translational research. The structured mentoring program will assure that these young investigators can become integrated into the wide number of translational cancer research opportunities in prevention and control. Importantly, these scholars and their training backgrounds will not be limited by U.S. residency requirements, and therefore candidates can be drawn from the diverse, international community of cancer trainees. By the year 2050, two-thirds of all cancer in the world will be diagnosed in Asia and we intend for the Abeloff Scholars-in-Training program to increase the breadth and depth of collaborative research efforts and impact around the world.
The Martin D. Abeloff Scholars Program will train and support outstanding investigators, mentors, and young scientists whose work will help change, forever, how cancer is managed.